SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study
Go back to SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study| (NASDAQ: SOPH) | Delayed: 7.61 -0.06 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.67 | 52 Week High | $ | |||
| Open | $7.67 | 52 Week Low | $ | |||
| Day High | $7.76 | P/E | N/A | |||
| Day Low | $7.39 | EPS | $ | |||
| Volume | 355,627 | |||||
